Resveratrol reliefs DEHP-induced defects during human decidualization

Area of Science:

• Reproductive Biology
• Toxicology
• Pharmacology

Background:

• Di-(2-Ethylhexyl) phthalate (DEHP) is a common plastic additive linked to female reproductive disorders.
• Decidualization, a critical process for human pregnancy, involves endometrial remodeling.
• Resveratrol (RSV) is a natural compound with known therapeutic effects on reproductive issues.

Purpose of the Study:

• To investigate the impact of DEHP on cellular decidualization in vitro.
• To explore the potential of Resveratrol (RSV) in mitigating DEHP-induced reproductive toxicity.
• To elucidate the molecular mechanisms underlying DEHP's effects and RSV's protective role.

Main Methods:

• Cell proliferation assays to assess DEHP's effect on cell viability.
• In vitro induction of decidualization.
• Quantitative real-time PCR and Western blot analysis for molecular changes.
• Immunofluorescence and RNA-seq for comprehensive analysis of cellular and molecular responses.

Main Results:

• DEHP exposure was found to impair cell viability and disrupt decidualization markers.
• DEHP induced alterations in cell morphology and ERα nuclear entry.
• Resveratrol (RSV) administration successfully upregulated decidual molecules and restored ECM remodeling genes.
• RNA-seq analysis confirmed DEHP's detrimental effects and RSV's restorative actions.

Conclusions:

• DEHP exposure significantly hinders the decidualization process, potentially contributing to female reproductive disorders.
• Resveratrol (RSV) demonstrates a significant protective effect against DEHP-induced decidualization defects.
• RSV presents a promising therapeutic candidate for addressing DEHP-related reproductive health issues.